Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice (vol 55, pg 2162, 2023)EXPERIMENTAL AND MOLECULAR MEDICINEIF12.92023-10-020OAAI
Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in miceEXPERIMENTAL AND MOLECULAR MEDICINEIF12.92023-09-016OAAI
Cancer type classification using plasma cell-free RNAs derived from human and microbesELIFEIF02022-07-1133OA
Mutant Kras and mTOR crosstalk drives hepatocellular carcinoma development via PEG3/STAT3/BEX2 signalingTHERANOSTICSIF13.32022-01-0110OAAI
p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinomaJOURNAL OF HEPATOLOGYIF332021-01-0160OAAI
Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1PHYTOMEDICINEIF8.32019-09-0125PREAI
ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axisANLN诱导的EZH2上调通过介导miR-218-5p/LASP1信号轴促进胰腺癌进展JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHIF12.82019-08-0880OAAI
PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cellsCELL DEATH & DISEASEIF9.62019-08-0838OAAI